FDAFDA · Food and drugs·Recall number D-0502-2024
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
Published May 29, 2024 · Recall initiated: April 22, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Release Testing: Out of specification for particulate matter test.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- XELPROS
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- TX, PA
- Lot
- Lot #: HAD3383A, Exp 8/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.